(1)
Migden, M.; Rischin, D.; Sasane, M.; Mastey, V.; Pavlick, A.; Schmults, C.; Chen, Z.; Guminski, A.; Hauschild, A.; Bury, D.; Hudgens, S.; Chang, A. L.; Rabinowits, G.; Ibrahim, S.; Fury, M.; Lowy, I.; Li, S.; Chen, C.-I. Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients With Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial. J of Skin 2021, 5, s5.